Wedding Season Stocks: 50 Lakh Weddings Boost Market
India's winter wedding season with 45-50 lakh weddings between November-December 2025 creates investment opportunities in jewellery, hospitality and travel stocks. Expert picks revealed.
India's winter wedding season with 45-50 lakh weddings between November-December 2025 creates investment opportunities in jewellery, hospitality and travel stocks. Expert picks revealed.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced single-use systems and filtration technologies.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced drug delivery systems and filtration technologies.
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma shares list on BSE and NSE today after 93.72 times subscription. Grey market signals 20% premium debut. Full details on pricing and investor response.
Is the US stock market heading for a crash? Experts are divided as S&P 500 gains 16% and Nasdaq surges 20% YTD. Learn about the risks and opportunities for Indian investors.
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
Australian shares plummeted to five-month lows as mining, banking, and technology stocks faced heavy losses. The S&P/ASX 200 index dropped 1.6% amid global valuation concerns. Read full analysis.
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Evexia Lifecare share price gained over 3% with heavy trading volumes. Discover the Q2 FY26 results showing a sharp profit fall and the stock's long-term decline. Read analysis before investing.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.